South Korea to Educate Patients About Lab Tests
|
By LabMedica International staff writers Posted on 23 Jul 2012 |
|
AACC 2012: South Korea joins a global network informing patients about lab tests.
Lab Tests Online-KR (South Korea), the South Korean version of the award-winning patient education website, Lab Tests Online, was launched at the annual American Association for Clinical Chemistry (AACC) meeting held in Los Angeles (CA, USA) July 15-19, 2012.
The new website was developed in partnership with the Korean Society for Laboratory Medicine (KSLM). During the last year, a team of KSLM editors translated the content found on the US version of Lab Tests Online and adapted it to Korean policy and practice.
“Lab Test Online welcomes KSLM to the international community of laboratory professionals who are committed to helping patients understand this vital aspect of medicine,” said D. Robert Dufour, MD, executive editor of Lab Tests Online. “With the addition of South Korea, Lab Tests Online will continue to improve health literacy and patient outcomes around the world.”
Yeo-Min Yun, MD, director of public relations and publications of KSLM commented, “The patients as well as the doctors and laboratory scientists of Korea will all benefit from this new partnership.”
Based in Washington DC (USA), Lab Tests Online is considered a global standard for patient education. Lab Tests Online has sites active in the native language of almost one-third of the world’s population. Countries where Lab Tests Online has been localized include the US, China, Brazil, Spain, France, Germany, Italy, Portugal, Poland, Hungary, Czech Republic, Greece, Turkey, UK, and Australia.
Related Links:
Lab Tests Online-KR
Lab Tests Online-KR (South Korea), the South Korean version of the award-winning patient education website, Lab Tests Online, was launched at the annual American Association for Clinical Chemistry (AACC) meeting held in Los Angeles (CA, USA) July 15-19, 2012.
The new website was developed in partnership with the Korean Society for Laboratory Medicine (KSLM). During the last year, a team of KSLM editors translated the content found on the US version of Lab Tests Online and adapted it to Korean policy and practice.
“Lab Test Online welcomes KSLM to the international community of laboratory professionals who are committed to helping patients understand this vital aspect of medicine,” said D. Robert Dufour, MD, executive editor of Lab Tests Online. “With the addition of South Korea, Lab Tests Online will continue to improve health literacy and patient outcomes around the world.”
Yeo-Min Yun, MD, director of public relations and publications of KSLM commented, “The patients as well as the doctors and laboratory scientists of Korea will all benefit from this new partnership.”
Based in Washington DC (USA), Lab Tests Online is considered a global standard for patient education. Lab Tests Online has sites active in the native language of almost one-third of the world’s population. Countries where Lab Tests Online has been localized include the US, China, Brazil, Spain, France, Germany, Italy, Portugal, Poland, Hungary, Czech Republic, Greece, Turkey, UK, and Australia.
Related Links:
Lab Tests Online-KR
Gold Member
Aspiration System
VACUSAFE
Hematology Consumables
Bioblood Devices
Immunofluorescence Analyzer
IFA System
Latest Technology News
- AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
- Agentic AI Platform Supports Genomic Decision-Making in Oncology
- Algorithm Panel Aids Liver Fibrosis Assessment and Liver Cancer Surveillance
- Mailed Screening Kits Help Reduce Colorectal Cancer Screening Gaps
- AI-Enabled Assistant Unifies Molecular Workflow Planning and Support
- AI Tool Automates Validation of Laboratory Software Configuration Changes
- Point-of-Care Testing Enhances Health Literacy and Self-Management in Chronic Disease
- Fully Automated Sample-to-Insight Workflow Advances Latent TB Testing
- Tumor-on-a-Chip Platform Models Pancreatic Cancer Treatment Response
- New Platform Captures Extracellular Vesicles for Early Cancer Detection
- Microfluidic Single-Cell Assay Predicts Breast Cancer Risk
- AI Tool Predicts Non-Response to Targeted Therapy in Colorectal Cancer
- Integrated System Streamlines Pre-Analytical Workflow for Molecular Testing
- Noninvasive Sputum Test Detects Early Lung Cancer
- New AI Tool Enables Rapid Treatment Selection in Pediatric Leukemia
- Rapid Biosensor Detects Drug Sensitivity in Breast Tumors
Channels
Clinical Chemistry
view channel
Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features
Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more
Plasma Vitamin C Levels Associated with Brain Structure and Connectivity in Aging
Previous studies have linked vitamin C–rich diets with lower risk of cognitive impairment in older adults. However, few investigations have directly examined blood plasma vitamin C in relation to brain... Read more
Mass Spectrometry Detects Tumor Metabolites for Cancer Monitoring
Cancer’s altered metabolism complicates how clinicians detect and monitor tumors, because nutrient use can shift with context and time. Measuring small-molecule metabolites that distinguish malignant from... Read more
Urinary Biomarker Assay Predicts Kidney Disease Progression Beyond Standard Measures
Many patients with type 2 diabetes and chronic kidney disease continue to experience progressive renal decline, yet conventional markers such as albuminuria and estimated glomerular filtration rate (eGFR)... Read moreMolecular Diagnostics
view channel
Ultrasensitive HPV Blood Test Predicts Early Recurrence in Head and Neck Cancer
Human papillomavirus (HPV)-associated head and neck cancers are frequently treated with surgery, but some patients experience recurrence due to residual microscopic disease. Postoperative decisions about... Read more
New Library Normalization and Amplification Tools Support Oncology Sequencing
High-throughput next-generation sequencing (NGS) laboratories continue to grapple with uneven library pooling and amplification artifacts that can degrade variant calling accuracy and increase reruns.... Read more
Hematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read more
Immunology
view channel
Aptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection
Rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can undermine existing molecular diagnostics, especially when assays target small viral components. Double-antibody sandwich... Read more
Study Points to Autoimmune Pathway Behind Long COVID Symptoms
Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more
Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read more
Microbiology
view channel
TORCH Infection Trends Point to Need for Tailored Screening in Pregnancy
Congenital TORCH infections can be asymptomatic during pregnancy yet cause stillbirth, birth defects, and lifelong disability in infants. Many regions still lack robust surveillance to guide testing and... Read more
New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs
Clostridioides difficile infections remain a persistent threat in hospitals and communities, affecting about 500,000 people in the United States each year. Severe cases can be fatal within 30 days of diagnosis,... Read more
Pathology
view channel
Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer
Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
AI Tool Speeds Brain Tumor Classification from Routine Histology Slides
Accurate classification of brain and spinal cord tumors increasingly depends on molecular profiling alongside histology, but access to such testing remains limited and results can take about two weeks.... Read more
IHC Companion Diagnostic Standardizes Mismatch Repair Testing for Cancer Immunotherapy
Deficient DNA mismatch repair is an established predictive biomarker for response to immune checkpoint inhibitors, yet access to standardized assessment has varied across tumor types. Cancer remains the... Read more
Technology
view channel
AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
Oncology teams must manage growing volumes of genomic data, rapidly evolving clinical trial options, and frequently updated care guidelines, all within tight clinic schedules. Translating complex tumor... Read more
Agentic AI Platform Supports Genomic Decision-Making in Oncology
Oncology care teams increasingly face the challenge of managing complex molecular diagnostics, evolving treatment options, and extensive electronic health record documentation. Translating multimodal data... Read more
Industry
view channel
Open-Source Consortium Aims to Standardize Digital Pathology Workflows
Digital pathology is expanding rapidly as laboratories adopt whole-slide imaging and computational tools to meet growing diagnostic and biomarker-testing demand. However, fragmented software infrastructure... Read more
